By Rebecca Robbins and Benjamin Mueller from NYT Business https://ift.tt/2VfBdeB
via IFTTT After Admitting Mistake, AstraZeneca Faces Difficult Questions About Its Vaccine Some trial participants only got a partial dose of AstraZeneca’s vaccine. Experts said the company’s spotty disclosures have eroded confidence. Business New York Times November 24, 2020 at 06:00PM
No comments:
Post a Comment